A middle aged lady had been admitted feeling generally unwell, with a cough, systemic symptoms, and she had HIV.
This was all elicited from the history and none of it was remarkeable, but as the story unfolded tears ran down her cheeks.
I tried to comfort her, less with words than a hand on the shoulder, and she explained that she had not been on antiretroviral treatment (for HIV) for over 5 months. This was largely due to circumstances outside her control, but she was sincerely upset at the potential state of her health after missing such crucial treatment for so long.
I took bloods for CD4 count and viral load, both of which were subsequently very poor. The CD4 was 17, and the viral load very high. One year previously, her viral load was undetectable.
Tests for TB and cryptococcal antigen (routinely tested for if CD4 counts are below a certain threshold) were both negative. She was commenced on empirical treatment for a chest infection and referred to the medical team.
HIV, CD4 and Viral Load
Within 2 -4 weeks but up to 3 months after HIV infection, primary HIV infection (also called seroconversion) can occur. This often presents as flu like symptoms, also maculopapular rash, pharyngitis and other sexually transmitted diseases may present.
In the absence of diagnosis or treatment, the patient my remain clinically well for up to 3 years, as “latent” HIV, with a CD4 count slowly dropping.
The CD4 count can transiently drop to <200cells mm="" sup="">3 200cells>
during which time the patient may be exposed to opportunistic infections e.g. PCP (Pneumocystis jiroveci – pneumonia).
Antiretroviral treatment is now very effective and can maintain good quality of life and stable disease control.
Poorly controlled disease will result in progressively reduced CD4 levels – normal levels being 500 – 1500 x 106 cells / mm3.
Below 500 opportunistic fungal, bacterial and viral infections may present, as well as TB infection.
Below 200 is technically AIDS – Acquired Immune Deficiency Syndrome, when there is susceptibility to PCP, Toxoplasma,Cryptococcus, Cryptosporidia and Kaposi sacoma.
Below 100, atypical mycobacteria, CMV, aspergillus and lymphoma may occur.
Viral load is a marker of response to treatment – if viral load is undetectable the person is unable to pass on the disease.
Current guidelines from WHO recommend starting ARV treatment for anyone diagnosed with HIV – this has been shown to improve response and reduced chance of transmission. Years previously practice was to delay treatment until CD4 counts reached around 300, based on concerns over viability of long term adherence, and side effects of ARV treatment.
https://www.who.int/hiv/pub/guidelines/earlyrelease-arv/en/
Comments
Post a Comment